Area of research
Molecular Biology · Surgery
Research interest
Research interests include Amyloidosis: Diagnosis, Treatment, Outcomes, Mechanical Circulatory Support Devices, Parathyroid Disorders and Treatments, and Cardiac Structural Anomalies and Repair.
Long-Term Efficacy and Safety of Acoramidis in ATTR-CM: Initial Report From the Open-Label Extension of the ATTRibute-CM Trial
Abstract 4147141: Relationship Between CVH and Survival in the Acoramidis Treated Participants Within ATTRibute-CM
Clinical and genetic profile of patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS): 14-year update
Sex Differences in Wild-Type Transthyretin Amyloidosis: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)
Liver‐directed drugs for t<scp>ransthyretin‐mediated</scp> amyloidosis
Management and Outcomes of Cardiogenic Shock in Cardiac ICUs With Versus Without Shock Teams
Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy
Screening for ATTR amyloidosis in the clinic: overlapping disorders, misdiagnosis, and multiorgan awareness
Impact of Delayed Diagnosis and Misdiagnosis for Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM): A Targeted Literature Review
De Novo vs Acute-on-Chronic Presentations of Heart Failure-Related Cardiogenic Shock: Insights from the Critical Care Cardiology Trials Network Registry
The Range of Cardiogenic Shock Survival by Clinical Stage: Data From the Critical Care Cardiology Trials Network Registry
Sex-Related Risk of Cardiac Involvement in Hereditary Transthyretin Amyloidosis
Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes Survey
Expert opinion on monitoring symptomatic hereditary transthyretin-mediated amyloidosis and assessment of disease progression
Natural History and Progression of Transthyretin Amyloid Cardiomyopathy: Insights from ATTR-ACT
Quality of Life in Patients With Heart Failure With Recovered Ejection Fraction
Best Practices in Specialized Amyloidosis Centers in the United States: A Survey of Cardiologists, Nurses, Patients, and Patient Advocates
Estimating the health benefits of timely diagnosis and treatment of transthyretin amyloid cardiomyopathy
ATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtable
Continuous Wearable Monitoring Analytics Predict Heart Failure Hospitalization
Use of Temporary Mechanical Circulatory Support for Management of Cardiogenic Shock Before and After the United Network for Organ Sharing Donor Heart Allocation System Changes
Efficacy of Tafamidis in Patients With Hereditary and Wild-Type Transthyretin Amyloid Cardiomyopathy
Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner
Utility of Biomarkers in Cardiac Amyloidosis
Patient Perspectives on the Completion and Use of Patient-Reported Outcome Surveys in Routine Clinical Care for Heart Failure
Immune checkpoint inhibitors in heart or lung transplantation: Early results from a registry initiative
Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis
Transthyretin Stabilization by AG10 in Symptomatic Transthyretin Amyloid Cardiomyopathy
Shock Team Approach in Refractory Cardiogenic Shock Requiring Short-Term Mechanical Circulatory Support
Post-transplant outcome in patients bridged to transplant with temporary mechanical circulatory support devices